128 related articles for article (PubMed ID: 2833402)
1. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
Roed H; Vindeløv LL; Christensen IJ; Spang-Thomsen M; Hansen HH
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):247-53. PubMed ID: 2833402
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
3. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
[TBL] [Abstract][Full Text] [Related]
4. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the EORTC Lung Cancer Working Party.
Klastersky J
Cancer Treat Rev; 1988 Jun; 15 Suppl B():33-40. PubMed ID: 2841022
[No Abstract] [Full Text] [Related]
7. Chemosensitivity test for human small cell lung cancer cell lines in vitro.
Takahashi H; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sano T; Nakano H; Nakagawa K; Sakurai M
Jpn J Clin Oncol; 1986 Sep; 16(3):253-60. PubMed ID: 3022034
[TBL] [Abstract][Full Text] [Related]
8. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
[TBL] [Abstract][Full Text] [Related]
10. In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve.
Kobayashi K; Kudoh S; Takemoto T; Hino M; Hayashihara K; Nakahiro K; Ando M; Niitani H
J Cancer Res Clin Oncol; 1995; 121(12):715-20. PubMed ID: 7499442
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and teniposide chemotherapy for advanced non-small cell lung cancer.
Iberti V; Donadio M; Giaccone G
Eur J Cancer; 1991; 27(9):1104-6. PubMed ID: 1659849
[TBL] [Abstract][Full Text] [Related]
12. Review of therapeutic trials of carboplatin in lung cancer.
Bunn PA
Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
[TBL] [Abstract][Full Text] [Related]
13. Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
Goss GD; Vincent M; Corringham R; Germond C; Sinoff C; Kane G; Rowen J; Corringham S; Dhaliwal H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):69-74. PubMed ID: 1329228
[TBL] [Abstract][Full Text] [Related]
14. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
[TBL] [Abstract][Full Text] [Related]
15. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
[TBL] [Abstract][Full Text] [Related]
17. Can Carboplatin replace Cisplatin in small cell lung cancer?
Noronha V
Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
[No Abstract] [Full Text] [Related]
18. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Fan Y; Huang ZY; Zhang YP; Sun L
Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
[TBL] [Abstract][Full Text] [Related]
19. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.
Kalemkerian GP; Ou X
Cancer Chemother Pharmacol; 1999; 43(2):145-50. PubMed ID: 9923820
[TBL] [Abstract][Full Text] [Related]
20. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
